Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial

NCT03318783 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.

NCT NCT03318783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03318783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subarachnoid Hemorrhage and Soluble Epoxide Hydrolase Inhibition Trial
Lead sponsor
Oregon Health and Science University
Phase
Phase 1/2
Overall status
Completed
Start date
May 2, 2018
Completion date
January 9, 2020
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

delayed cerebral ischemia, endothelial dysfunction, subarachnoid hemorrhage, aneurysmal, vasospasm, cerebral